Precise and efficient models for cutting-edge disease research.
EditCo’s cutting-edge CRISPR technology ensures accurate and efficient gene editing while maintaining iPSC quality, pluripotency, and overall cell integrity. Our automated platform, optimized guide design, and superior reagents enable high-efficiency knock-ins and knockouts, minimizing errors and off-target effects. With a focus on delivering reliable and functional gene modifications, our robust process allows researchers to confidently assay gene functions, model diseases, and explore new therapeutic targets.
Whether you need precise knockouts or complex knock-ins, EditCo’s advanced editing solutions provide the accuracy and consistency required for high-impact scientific discoveries in biomedical research.
Disrupt your target gene to assess its role in a phenotype or cellular function.
Gene-Disease Linkage:
Investigate genetic factors in neurodegenerative diseases using edited iPSCs and neuronal cell types.
Pathway Analysis:
Knock out genes in your disease pathway. Differentiate cells into disease-relevant types and test for drug targets.
Target Validation:
Validate targets in CRISPR-edited iPSCs to confirm gene-disease linkage in cell models.
XDel Knockout Cell Pools and Clones
XDel is a CRISPR technology for precise, efficient gene editing. With a unique guide RNA design, it ensures reproducible knockouts without affecting pluripotency or cell integrity, accelerating research in gene function, disease modeling, and drug development.
– High Efficiency: Superior editing and consistent knockouts.
– Reliable Results: Persistent protein depletion validated through assays.
– Reproducibility: Minimized variability for dependable outcomes.
Features
– Cell Source: EditCo or customer supplied.
– Available Edits: Indel, fragment deletion, homozygous, or heterozygous.